Annie A. Mavian

Endocrinology
13652 Cantara St
Panorama City, CA 91402

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes.

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes.

Journal: Diabetes care
Published: September 27, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026